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Objectives: To evaluate a new imaging technique, for diagnosis of prosthetic vascular graft infection. Avidin is a protein 
which accumulates nonspecifically atsites of inflammation or infection. Due to its extremely low dissociation constant with 
biotin sites of infection can be imaged, using avidin as a pre-target, followed by injection of 111In-labelled biotin. This 
technique is much simpler than the common scintigraphic methods which employ labelling of blood components and its 
target-to-background ratio is greater than the methods employing radiolabelled proteins. 
Design: Prospective clinical study. 
Setting A single department of vascular surgery and one of nuclear medicine of a Northern Italian hospital. 
Materials" Between May 1993 and May 1994, 31 grafts in 26 patients were studied; the series included 23 men and three 
women with a mean age of 65.5 years (range 54-76 years). The prosthetic graft (Dacron -16, ePTFE -15) were: aortoaortic 
5, aortobifemoral 15, aortoiliac 1, and femoropopliteal 10. Sixteen patients were suspected of having a vascular graft 
infection (Group A), the other 10 patients erved as controls (Group B). 20 mg of Avidin were injected iv, followed 24 h 
later by i.v. injection of 500 ~g of Biotin labelled with 74 MBq of II1In. 
Chief outcome measures: Whole-body imaging was performed at 10 min and 2 h post-injection, along with SPECT 
imaging when indicated. Scan results were correlated with the traditional imaging modalities and the clinical outcome of 
the patients. 
Main results: In Group A: two patients (three grafts) were excluded from the study, there were six true-positives, one false- 
positive and 11 true-negatives. Results in Group B: 10 true-negatives. The overall sensitivity was 100%, the specificity 
95%, the accuracy 96%, the positive predictive value 86% and the negative predictive value 100%. 
Conclusions" These data suggest hat Avidin/lll ln-labelled Biotin scintigraphy is a useful non invasive diagnostic method 
for early diagnosis of suspected prosthetic vascular graft infection. 
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Introduction 
Prosthetic graft infection is the most dreadful compli- 
cation of arterial reconstructive surgery and despite 
recent advancements in treatment, mortality and 
major morbidity (i.e. amputations) continue to be 
worryingly high (25-75%) especially if the diagnosis i  
late and complications such as sepsis, graft enteric 
erosion or fistula or anastomotic aneurysms or suture 
line disruption are present. 1'2 The incidence of pros- 
thetic graft infection reported in the literature ranges 
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between 1 and 6% and has declined in the last two 
decades, being less than 1% in several reports; 1"2 
however due to the growth in the use of prostheses the 
topic remains an important one and an early and 
accurate diagnosis of vascular graft infection is of 
major interest to vascular surgeons. 
A wide variety of imaging techniques are available 
for the diagnosis of graft infection; most currently 
employed methods however, lack specificity partic- 
ularly in the early phase of infection. Several different 
isotope scanning techniques have also been used such 
67 111 99rn as scanning with Gallium, Indium or Techne- 
tium-Hydroxymethylpropilamineoxine (HMPAO) 
labelled white blood cells (WBC). 3-9 These methods 
are clinically accepted as reasonably specific and 
sensitive; yet their widespread use is prevented by the 
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complexity of the procedure: the radiolabelled-WBC 
method requires laborious separation, labelling and 
reinjection of the labelled autologous leukocytes; 
furthermore the method is not entirely free from the 
risk of infection. Radiolabelled nonspecific polyclonal 
immunoglobulin (IgG) and other proteins (albumin) 
have also been used to localise infection. 1°-12 Their use 
to image sites of focal inflammation/infection is 
probably due to nonspecific accumulation of the 
protein resulting from increased vascular permeabil- 
ity. 13'14 Unfortunately radiolabelled proteins also accu- 
mulate in normal organs such as the liver and have a 
slow clearance of the label from the circulation, thus 
restricting early imaging. 
Avidin/biotin is a new method that not only greatly 
simplifies the currently used radiolabelled-WBC scans 
but has also significant advantages over the radi- 
olabelled-proteins method. This method implements 
the "pre-targeting" concept (Fig. 1): an unlabelled 
bifunctional compound (avidin) is administered first, 
this protein having 24 h to accumulate in the target 
(infection) and to be excreted in the urine. Radi- 
olabelled biotin is then administered, which has an 
extremely high affinity for avidin (Ka = 1015) and a 
rapid whole body clearance. The net result is that the 
localisation of the radiolabel in all organs (except 
kidneys) and in the bloodstream is reduced and the 
target-to-background ratio is significantly increased 
by the pre-targetting. 15'16 
The aim of this research was to investigate he use of 
rain-labelled avidin/biotin scintigraphy in the man- 
agement of patients with clinically suspected infection 
of a prosthetic vascular graft. 
Materials and Methods 
Patients 
From May 1993 through May 1994 we studied 31 
vascular grafts in 26 patients: 23 males and three 
females with a mean age of 67 years (range 54 to 76 
years). Five patients had multiple graft replacements. 
The vascular econstructions included five aortic, 15 
aortobifemoral, 10femoropopliteal and one aortoiliac, 
and the graft material was Dacron in 16 cases and 
ePTFE in 15 cases (Tables 1 and 2). 
The patients were divided into two groups: Group 
A comprised 16 patients with suspected vascular graft 
infection whose grafts were implanted I to 36 months 
earlier (mean 6.1 months). Group B comprises 10 
patients operated on 2 to 20 months earlier (mean 6 
months), with an uneventful postoperative course 
who served as controls. 
The patients in group A fulfilled one or more of the 
following criteria: fever (10), draining inguinal wound 
(4), positive blood cultures (6), intraoperative bowel 
(3) or ureter (1) lesion, periprosthetic fluid collection at 
postoperative ultrasonography (2). 
All patients with suspected infection were managed 
according to our usual clinical practice, undergoing 
operation when necessary and, in these cases, micro- 
biological samples were obtained. The surgeons in 
charge of the patients were unaware of the results of 
the scintigraphy until the end of the study. Non- 
operated patients were followed for 1 to 12 months 
(mean 7 months) to evaluate the clinical outcome. 
Informed consent was obtained from each patient 
before the study, which was approved by the ethical 
committee of our institution. 
Avidin/Biotin scan 
Pure hen egg avidin was obtained from "Societa 
Prodotti Antibiotici" (S.p.a.), Milan, Italy. Diethylene 
triamine pentacetic acid (DTPA) conjugated biotin was 
obtained from Sigma (St. Louis, MO, U.S.A.). DTPA- 
conjugated biotin was diluted in phosphate buffer 
saline (PBS), pH 7.4, to a concentration of 2 mg/ml. 
The solution was sterilised by 0.22 ~m Millipore 
filtration, mInC13 was diluted in citrate buffer (0.02 M; 
pH 6.5) to 740 kBq/~l. Reagents were mixed and 
allowed to react for 10 min at room temperature. 
Paper chromatography confirmed that more than 98% 
of the 111In was bound to conjugate. The ability to bind 
avidin after labelling was verified by fast protein 
liquid chromatography (FPLC) (Pharmacia, Sweden); 
no loss of reactivity was observed. 
Twenty milligrammes of Avidin were added to 100 
ml of physiological saline solution and administered 
intravenously over 30 min. Twenty-four hours later, 
500 ~g of Biotin labelled with 74 MBq of rain were 
administered intravenously as a bolus injection. A 
whole-body scan was acquired 10 min after the 
injection of labelled Biotin using a Toshiba GCA 901 
SA/W2 gamma camera. Medium energy collimators 
were used, with 15% energy windows centered 
around the 167 keV and 256 keV energy peaks of lllIn. 
Since the urinary tract is the route of elimination of 
labelled Biotin, patients were asked to urinate prior to 
scanning as bladder activity significantly interfered 
with the evaluation of the inguinal region. At I h post- 
injection, Single Photon Emission Computed Tomog- 
raphy (SPECT) imaging was performed when con- 
sidered helpful, (64 × 64 matrix, 64 projections over 
360 °) using a Siemens orbiter 7500 gamma camera 
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Fig. 1. The "pre-targeting" concept of avidin/biotin scan: (a) the unlabelled compound (Avidin) is administered first; (b) this protein has 
24 h to accumulate in the target (infection) and to be excreted in the urine; (c) radiolabelled Biotin is then administered, Biotin has an 
extremely high affinity for Avidin (Ka = 1015) and a rapid whole body clearance; (d) the net result is the accumulation of the radiolabel in 
the target (graft infection) with a reduction of the localization of the radiolabel in all organs (except kidneys) and in the bloodstream. The 
target-to-background ratio is significantly increased by the pre-targetting. 
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Table 1. Clinical features and scan results of the patients of group A in whom a vascular graft infection was suspected 
Patient Age/ Graft Graft Presentation Scan Organism Treatment Outcome 
no. sex site type findings 
1 63/M Ao-Ao Dacron Fever Positive Enterococcus Antibiotics 
2 75/M Ao-Bf Dacron Positive Surgical drainage 
+ antibiotics 
3 65/M FP sx ePTFE Negative Pseudomonas Surgical drainage 
FP dx Dacron Positive aeruginosa + antibiotics 
4 61 / M Ao-Bf Dacron Negative Staphylococcus Surgical drainage 
FP dx Dacron Positive aureus + antibiotics 
5 64/M Ao-Bf Dacron Fever Negative Enterococcus Surgical drainage 
Edema of thigh abscess 
6 75/M FP sx ePTFE Fever Negative Staphylococcus Graft explantation 
FP dx Dacron Positive aureus 
7 76/M Ao-Ao Dacron Negative No organism Antibiotics Settled 
8 54/M Ao-Bf Dacron Positive Streptococcus D Graft explantation Settled 
+ axillo-bifemoral 
reconstruction 
72/M Ao-Bf Dacron Negative No organism Antibiotics 
64/M FP sx Dacron Positive Staphylococcus Antibiotics 
FP dx PTFE Negative epidermidis 
73/M Ao-Bf Dacron Negative No organism No treatment 
60/F FP sx Dacron Antibiotics 
FP dx Dacron 














10 Draining inguinal 
wound 
11 Periprosthetic 
fluid at U.S. 
Staphylococcus 
aureus  
Died of endocarditis 






Died of acute 
myocardial infarction 
Forefoot amputation 
12 Draining inguinal Negative Staphylococcus 
wound Positive epidermidis 
13 Intraoperative Negative No organism 
ureteric lesion 
Fever 
14 69/M Ao-Bf Dacron Intraoperative Negative No organism Antibiotics Settled 
bowel esion 
Fever 
15 74/M Ao-Bf ePTFE Fever Negative Staphylococcus Antibiotics Settled 
aureus  
16 76/M FP sx Dacron Periprosthetic fluid Positive Staphylococcus Surgical drainage Settled 
collection at U.S. epidermidis + antibiotics 
Settled 




* Patients excluded from the study. 
Ao-Ao = Aortoaortic bypass graft; Ao-Bf = Aortobifemoral bypass graft; FP = femoropopliteal bypass graft. 
Table 2. Clinical features and scan results of the patients of group B 
with uneventful postoperative course who served as controls 
Patient Age Graft Graft Scan Outcome 
no. (Yr / sex) site type findings 
1 70/M Ao-Ao ePTFE Negative Settled 
2 73/F Ao-Ao ePTFE Negative Settled 
3 61/M Ao-Bf ePTFE Negative Settled 
4 72/M Ao-Bf ePTFE Negative Settled 
5 62/M Ao-Bi ePTFE Negative Settled 
6 59/M Ao-Bf ePTFE Negative Settled 
7 60/M Ao-Bf ePTFE Negative Settled 
8 55/M Ao-Bf ePTFE Negative Settled 
9 74/M Ao-Ao ePTFE Negative Settled 
10 59/F Ao-Bf ePTFE Negative Settled 
Ao-Ao = Aortoaortic bypass graft; Ao-Bf = Aortobifemoral bypass 
graft; Ao-Bi = Aortoiliac bypass graft. 
equipped with a medium energy collimator. Recon- 
structed images were generated using a filtered back 
projection algorithm with a Hann filter (cutoff 0.5 
pixel-1), which is a mathematical process during 
tomographic reconstruction which reduces image 
noise. The delayed whole body scan was acquired at 2 
h post-injection. Scans were interpreted by two inde- 
pendent observers with no detailed knowledge of the 
study patients. The scans were evaluated qualitatively 
as positive or negative for graft infection. 
The proteins have been previously shown to be safe. 
Biotin is non immunogenic. The immunoresponse 
against avidin [human anti avidin response (HAAR)] 
was evaluated in 73 patients; 8/73 patients developed 
a weak HAAR response. 17 No allergic reaction ever 
developed in our previous or actual experience with 
this method. A recombinant avidin molecule with 
reduced immunogenicity is under development. 
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Results Discussion 
Two patients from Group A had to be excluded from 
the evaluation of the results: patient no.1 had an aortic 
graft and a positive scan with a strong clinical 
suspicion of graft infection from the diagnostic 
workup; however he died of endocarditis at an other 
hospital and autopsy was not available to confirm the 
diagnosis. Patient no. 10 had a bilateral femor- 
opopliteal bypass and the scan was positive over the 
left graft, unfortunately this patient was lost at follow- 
up. The final analysis was therefore performed on 28 
grafts in 24 patients. 
In group A seven grafts produced apositive scan: all 
were treated surgically. In one femoropopliteal graft 
(patient no. 3) the infection (sustained by Pseudomonas 
aeruginosa) seemed to be confined to the groin wound 
and did not apparently extend to the graft. Twelve 
months later the graft occluded requiring thrombect- 
omy, culture specimens were negative and the graft is 
patent with healed wound. This case was considered a 
false-positive. Three more cases of femoropopliteal 
graft infection were treated conservatively with debri- 
dement of the perigraft issue, irrigation and secon- 
dary healing. In one case a femoropopliteal graft had 
to be excised and a forefoot amputation was required 
due to the resulting critical ischaemia (Fig. 2). One 
case of groin infection in a patient with aortofemoral 
graft was treated surgically with debridement fol- 
lowed by irrigation and secondary healing (Fig. 3). 
Finally one case of aortic graft infection was treated 
with graft excision and axillofemoral reconstruction 
(Fig. 4). These six cases were considered true positives. 
In 11 grafts the scans were negative. Depending on the 
clinical situation, some of these patients received 
antibiotics and none of them had any further manifes- 
tations of graft infection at the follow-up. They were 
considered true-negatives. Patient no. 3 is worth 
mentioning since he received an aortofemoral graft 
and the avidin/biotin scan showed an intense uptake 
along the muscles of thigh but was negative as far as 
the graft was concerned (Fig. 5); CT confirmed 
multiple abscesses at the same level without involve- 
ment of the graft. The abscesses were drained success- 
fully but the patient died in hospital of an acute 
myocardial infarction. 
In all the 10 control cases the scans were negative, 
and they were also considered true negatives. The 
overall sensitivity was 100%, the specificity 95%, the 
accuracy 96%, the positive predictive value 86% and 
the negative predictive value 100%. All the procedures 
were well tolerated and no patient had any allergic 
manifestations. 
The epidemiological nd clinical features of vascular 
graft infections have changed during the last two 
decades. The relative incidence declined from over 5% 
to somewhere between 0.5 and 2% however due to the 
increased use of prostheses, the overall number of 
cases is not declining. This condition represents a
substantial risk to life as well as limb despite the 
improvements in antibiotic therapy and surgical treat- 
ment. As far as the final prognosis is concerned there 
is a great difference between chronic indolent infec- 
tions which may be sustained by less virulent patho- 
gens such as Staphylococcus epidermidis, Gram-negative 
bacteria or by biofilm producing Staphylococci, ~s-2° 
and full blown infections complicated by abscess 
formation, anastomotic aneurysms, suture-line rup- 
tures, or aortoenteric fistulae. 
Several different surgical alternatives to graft expla- 
nation and extra-anatomic bypass have been pro- 
posed, including local debridement and irrigation, 2~ in 
situ replacement with either antibiotic impregnated 
grafts, 22"23 allografts, 24 or other biological con- 
duits, 25'26 muscle or omental flaps 27 in association 
with different chronic antibiotic regimens. Whatever 
treatment is chosen, the stage of the graft infection at 
the time of diagnosis plays a crucial role in the 
determination of the final outcome of the disease. 
Unfortunately a standard iagnostic test for reliably 
diagnosing graft infection is not available, and the 
final judgment relies on the clinical picture together 
with an array of imaging modalities. Ultrasonography 
is a useful initial investigation providing information 
on graft patency, aneurysmal formation and perigraft 
fluid collection, but it has a low sensitivity and 
specificity. Arteriography, contrast sinography and 
gastroduodenoscopy have a role in selected cases, 
whereas CT and MR 28 imaging provide an anatomic 
delineation of the abdominal aorta, retroperitoneum 
and intraperitoneal organs. 29 In the last decade several 
different radioisotopic techniques have been 
employed and have proved to be useful in the 
diagnosis. 
The avidin/biotin technique has been formerly 
employed in oncologic studies 3° and to image infec- 
tion/inflammation i  patients with suspected sub- 
acute or chronic ostheomyelitis. ~s However, as far as 
we know, it has not been used for the detection of 
prosthetic vascular graft infection in humans. The 
theoretic advantages of this technique are that the pre- 
targeting of the infection site followed by the injection 
of a high affinity radiolabelled compound with a rapid 
clearance allows us to obtain an excellent arget to 
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(a) 
(b) 
111 Fig. 2. Patient with bilateral femoropopliteal grafts (case no. 6). Scintigraphy using avidin and In-labelled biotin reveals increased uptake 
along the path of the right graft (arrowheads); (a) whole body imaging, left picture is anterior view and right picture posterior view; (b) 
SPECT imaging. 
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(a) 
(b) 
Fig. 3. Patient with aortofemoral graft (Case no. 2). The avidin and ~lIn-labelled biotin scan shows a markedly increased uptake in the right 
femoral limb of the graft (arrowheads); (a) whole body imaging, left picture is anterior view and right picture posterior view; (b) SPECT 
imaging. 
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(a) 
(b) 
Fig. 4. Patient with aortofemoral graft (Case no. 8). The avidin and rain-labelled biotin scan shows increased tracer uptake along the length 
of the aortic graft (arrowheads); (a) whole body imaging, left picture is anterior view and right picture posterior view; (b) SPECT imaging 
confirms prosthetic infection. The slice in the bottom-right-han d corner is taken at a higher level, above the infection and demonstrates the 
difference in tracer uptake between the infected and uninfected part of the prosthesis. 
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(a) 
(b) 
Fig 5. Patient with aortofemoral graft (Case no. 5). The avidin and rain-labelled biotin scan is negative for prosthetic infection but shows 
intense uptake in the soft tissue of the right thigh (arrowheads). (CT scan confirmed multiple abscesses in the thigh); (a) whole body 
imaging, left picture is anterior view and right picture posterior view; (b) SPECT imaging. 
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background ratio with a simple and straightforward 
technique. 
The technique was always safe and well tolerated, 
and we believe that the results demonstrate a good 
accuracy and prompt us to obtain a larger experience 
with the technique in order to evaluate its real benefits 
to the patients. Future prospectives include the use of 
99mTc as the radiolabel and the injection of labelled 
Biotin only 4 h after Avidin, resulting in a single day 
procedure. 
We do not claim that this technique replaces clinical 
judgment or other well established imaging modali- 
ties. However if a radioisotopic technique is to be 
included in the evaluation protocol of patients with 
suspected vascular graft infection, the avidin/biotin 
scan may prove to be at least as accurate as the already 
existing techniques as well, being simple, safe and 
more cost-effective. 
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